Literature DB >> 17494074

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

Prasanna M Bhende1, Sarah J Dickerson, Xiaoping Sun, Wen-Hai Feng, Shannon C Kenney.   

Abstract

Epstein-Barr virus (EBV) establishes a latent form of infection in memory B cells, while antibody-secreting plasma cells often harbor the lytic form of infection. The switch between latent and lytic EBV infection is mediated by the two viral immediate-early proteins BZLF1 (Z) and BRLF1 (R), which are not expressed in latently infected B cells. Here we demonstrate that a cellular transcription factor that plays an essential role in plasma cell differentiation, X-box-binding protein 1 (XBP-1), also activates the transcription of the two EBV immediate-early gene promoters. In reporter gene assays, XBP-1 alone was sufficient to activate the R promoter, whereas the combination of XBP-1 and protein kinase D (PKD) was required for efficient activation of the Z promoter. Most importantly, the expression of XBP-1 and activated PKD was sufficient to induce lytic viral gene expression in EBV-positive nasopharyngeal carcinoma cells and lymphoblastoid cells, while an XBP-1 small interfering RNA inhibited constitutive lytic EBV gene expression in lymphoblastoid cells. These results suggest that the plasma cell differentiation factor XBP-1, in combination with activated PKD, can mediate the reactivation of EBV, thereby allowing the viral life cycle to be intimately linked to plasma cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494074      PMCID: PMC1933364          DOI: 10.1128/JVI.00154-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Plasma cell differentiation requires the transcription factor XBP-1.

Authors:  A M Reimold; N N Iwakoshi; J Manis; P Vallabhajosyula; E Szomolanyi-Tsuda; E M Gravallese; D Friend; M J Grusby; F Alt; L H Glimcher
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.

Authors:  J Lu; T A McKinsey; R L Nicol; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

4.  Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.

Authors:  D M Walling; C M Flaitz; C M Nichols; S D Hudnall; K Adler-Storthz
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

5.  Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane.

Authors:  Carole L Baron; Vivek Malhotra
Journal:  Science       Date:  2001-11-29       Impact factor: 47.728

6.  MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling.

Authors:  H Gruffat; E Manet; A Sergeant
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

7.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.

Authors:  T A McKinsey; C L Zhang; J Lu; E N Olson
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

8.  XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

Authors:  H Yoshida; T Matsui; A Yamamoto; T Okada; K Mori
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

9.  ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs.

Authors:  J Ye; R B Rawson; R Komuro; X Chen; U P Davé; R Prywes; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

10.  Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

Authors:  Wen-hai Feng; Jeffrey I Cohen; Steven Fischer; Li Li; Michael Sneller; Raphael Goldbach-Mansky; Nancy Raab-Traub; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  J Natl Cancer Inst       Date:  2004-11-17       Impact factor: 13.506

View more
  71 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Authors:  Aron R Marquitz; Anuja Mathur; Rachel Hood Edwards; Nancy Raab-Traub
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Integrated Epigenetic Mapping of Human and Mouse Salivary Gene Regulation.

Authors:  D G Michael; T J F Pranzatelli; B M Warner; H Yin; J A Chiorini
Journal:  J Dent Res       Date:  2018-11-04       Impact factor: 6.116

4.  Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.

Authors:  Jill K Countryman; Lyndle Gradoville; George Miller
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

5.  Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein.

Authors:  Christopher M Collins; Jeremy M Boss; Samuel H Speck
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

6.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.

Authors:  Loránd L Kis; Daniel Salamon; Emma K Persson; Noémi Nagy; Ferenc A Scheeren; Hergen Spits; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 9.  Modulation of the Translational Landscape During Herpesvirus Infection.

Authors:  Britt A Glaunsinger
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

Review 10.  The role of X-box binding protein-1 in tumorigenicity.

Authors:  Ayesha N Shajahan; Rebecca B Riggins; Robert Clarke
Journal:  Drug News Perspect       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.